← Back to Search

Telemedicine Assessment for Autism (TAP-P Trial)

Led By Zachary Warren, PhD
Research Sponsored by Vanderbilt University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Novel sample (n = 120): English/Spanish Speaking families with children 36-72 months of age, access to a device capable of supporting Zoom, and has not participated in a diagnostic evaluation
Be younger than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 2 years
Awards & highlights

TAP-P Trial Summary

This trialis developing a telemedicine tool to improve access to ASD diagnosis for underserved groups, such as those with long waitlists or long distances to care.

Who is the study for?
This trial is for preschool children aged 36-72 months who may have autism. It's open to English or Spanish-speaking families with access to a device that supports Zoom. The study includes kids both previously evaluated for autism and those not yet assessed.Check my eligibility
What is being tested?
The trial is testing the TAP-Preschool, a new telemedicine tool designed to assess the risk of autism in preschoolers remotely. It compares results from this tool with traditional in-person assessments to see if it can improve care access.See study design
What are the potential side effects?
Since this trial involves assessment tools rather than medication, there are no direct physical side effects expected. However, participating families might experience stress or anxiety related to the use of technology and concerns about their child's development.

TAP-P Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I speak English or Spanish, have a child aged 3-6, can use Zoom, and haven't had a diagnostic evaluation.

TAP-P Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Diagnostic Certainty: In-person assessment
Diagnostic Certainty: Tele-assessment
Family Satisfaction
+4 more

TAP-P Trial Design

1Treatment groups
Experimental Treatment
Group I: Tele-assessment + In-person assessmentExperimental Treatment1 Intervention
All families will receive an in-person tele-assessment appointment and an in-person evaluation.

Find a Location

Who is running the clinical trial?

Vanderbilt University Medical CenterLead Sponsor
856 Previous Clinical Trials
672,082 Total Patients Enrolled
15 Trials studying Autism Spectrum Disorder
2,360 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,688,957 Total Patients Enrolled
81 Trials studying Autism Spectrum Disorder
40,202 Patients Enrolled for Autism Spectrum Disorder
Zachary Warren, PhDPrincipal InvestigatorVanderbilt University Medical Center

Media Library

Tele-assessment + In-person assessment Clinical Trial Eligibility Overview. Trial Name: NCT05373173 — N/A
Autism Spectrum Disorder Research Study Groups: Tele-assessment + In-person assessment
Autism Spectrum Disorder Clinical Trial 2023: Tele-assessment + In-person assessment Highlights & Side Effects. Trial Name: NCT05373173 — N/A
Tele-assessment + In-person assessment 2023 Treatment Timeline for Medical Study. Trial Name: NCT05373173 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are actively engaged in this clinical research?

"Affirmative. Per information available on clinicaltrials.gov, this research project is actively selecting patients for recruitment. It was initially announced on June 1st 2022 and has been recently revised as of October 18th 2022; the aim being to enrol 150 participants at one site."

Answered by AI

Is the age limit for this trial restricted to adults over twenty-five?

"Consistent with the study's criteria, participants must be between 3 and 6 years old in order to qualify for enrollment."

Answered by AI

Is it possible for me to become a participant of this experiment?

"Individuals between the ages of 3 and 6 with autism spectrum disorders may be eligible for this research trial, which is looking to recruit up to 150 participants."

Answered by AI

Are participants still being accepted for this scientific research?

"Affirmative. Evidence posted on clinicaltrials.gov implies that this research endeavour, which was initially publicized on June 1st 2022, is actively recruiting subjects. Approximately 150 participants are being sought from a single medical station."

Answered by AI
~40 spots leftby Dec 2024